BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menzel D, Levi M, Dooijewaard G, Peters M, ten Cate JW. Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood. Ann Hematol 1994;68:43-8. [DOI: 10.1007/bf01695919] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Kuo KH, Khan S, Rand ML, Mian HS, Brnjac E, Sandercock LE, Akula I, Julien JP, Pai EF, Chesney AE. EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis. PLoS One 2016;11:e0149830. [PMID: 26934472 DOI: 10.1371/journal.pone.0149830] [Reference Citation Analysis]
2 Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Mooney JC, Watkins SL, Johnson R, Karpman D. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 2006;108:167-76. [PMID: 16514062 DOI: 10.1182/blood-2005-08-3219] [Cited by in Crossref: 138] [Cited by in F6Publishing: 131] [Article Influence: 8.6] [Reference Citation Analysis]
3 Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996;10:88-99. [PMID: 8611369 DOI: 10.1007/BF00863459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]